A great place to do great things: Developing game-changing technology at Abbott

AbbottScience has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized Abbott on its Top Employers list, which is based on an evaluation of 23 characteristics including financial strength, easy adaptation to change, and a research-driven environment.

At Abbott, scientists develop life-changing technologies that help people live their best lives through good health. From freeing people with diabetes from routine finger sticks(1), to building a cardiac device to save lives, to hunting for new virus mutations, every day Abbott employees are doing work that matters.

"Abbott's diverse businesses and product lines open up exciting career opportunities for our scientists across a range of technologies," said John Frels, Ph.D., chair of Abbott's Scientific Governing Board, which oversees the company's senior scientific career track.

"We strive to foster a culture of innovation and collaboration within our teams and in our work with others to gain fresh perspectives and further inspire our scientists to continue to push the boundaries on scientific advancements. This contributes to a strong, vibrant and fulfilling environment for scientists to develop their careers - and supports Abbott's long, successful legacy of scientific achievement and game-changing technology."

Our spirit of innovation and relentless focus on pushing the frontiers of science have allowed our company to thrive for more than 125 years. Today, we're working tirelessly to carry on that great legacy and to address some of healthcare's greatest challenges.

Some of Abbott's latest breakthroughs include:

  • A unified family of innovative next-generation diagnostics systems across lab disciplines that offer more efficiency, flexibility and confidence to health systems, and better help doctors and nurses get the results they need to improve decision-making and patient care.
  • Our revolutionary diabetes technology that replaces blood glucose monitoring, freeing people with diabetes from the pain and hassles of routine fingersticks.
  • Pioneering neuromodulation technology that can transform quality of life for many people who are otherwise unable to find relief from their chronic pain, while also reducing or stabilizing opioid use among patients battling chronic pain conditions.
  • A first-of-its-kind cardiac device that has transformed the treatment of certain kinds of mitral regurgitation (MR) for people who are too frail for open-heart surgery or those who are not candidates for surgery.
  • Groundbreaking research that has helped bring infant formula closer than ever to breast milk.

About the 2017 Science survey
The 2017 Science survey sought to identify the companies with the best reputations as employers. The findings are based on 6,950 completed surveys from readers of Science and other survey invitees. Survey respondents came from North America (65%), Europe (25%) and Asia/Pacific Rim (7%); 94% work in biotechnology, biopharmaceutical and pharmaceutical companies. Here's a complete list of the rankings, which also are available in the Oct. 20, 2017 print edition of Science.

About Abbott
At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life.

Today, 94,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

1. A finger prick test using a blood glucose meter is required during times of rapidly changing glucose levels when interstitial fluid glucose levels may not accurately reflect blood glucose levels or if hypoglycaemia or impending hypoglycaemia is reported by the system or when symptoms do not match the system readings.

Most Popular Now

A great place to do great things: Developing game-…

Science has spoken: Abbott (NYSE: ABT) is, again, among the best science-based companies to work for in the world. For the 14th year, the journal Science today recognized...

FDA accepts regulatory submission for Lynparza in …

AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has accepted and granted...

Alzheimer's disease might be a 'whole body' proble…

Alzheimer's disease, the leading cause of dementia, has long been assumed to originate in the brain. But research from the University of British Columbia and Chinese scie...

Cancer cells destroyed with dinosaur extinction me…

Cancer cells can be targeted and destroyed with the metal from the asteroid that caused the extinction of the dinosaurs, according to new research by an international col...

Novartis confirms leadership in multiple sclerosis…

Novartis today announced it will present 54 scientific abstracts from across its multiple sclerosis (MS) research portfolio at the 7th Joint European and Americas Committ...

Three of the most deadly cancers get critical fund…

Immunotherapy for leukemia patients has been nothing short of a miracle. Now scientists hope to use that science and other forms of gene therapy to tackle three of the de...

Transplanted hematopoietic stem cells reverse dama…

Researchers at University of California San Diego School of Medicine report that a single infusion of wildtype hematopoietic stem and progenitor cells (HSPCs) into a mous...

Amgen and Novartis announce expanded collaboration…

Amgen (NASDAQ:AMGN) and Novartis announced an expanded collaboration with the Banner Alzheimer's Institute (BAI) to initiate a new trial - the Alzheimer's Prevention Init...

Scientists find where HIV 'hides' to evade detecti…

In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memor...

'Precision Medicine' may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the w...

Novartis announces the planned acquisition of Adva…

Novartis announced today, that it has entered a memorandum of understanding with Advanced Accelerator Applications (AAA) under which Novartis intends to commence a tender...

China's out of control 'silent killer' affects one…

More than one-third of adults in China have high blood pressure - often dubbed the "silent killer" for its lack of symptoms - but only about one in 20 have the condition ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]